Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A Return To Restricted Pharmacy Networks Leaves NCPA Concerned

Executive Summary

In an interview, National Community Pharmacists Association CEO Doug Hoey expresses concern with restricted pharmacy networks in health plans as well as a lack of clarity about those restricted networks on the Medicare Part D Plan Finder website.

Advertisement

Related Content

CMS’ Long-Awaited AMP Rule Seeks To Clarify Uncertainties In Affordable Care Act’s Definition
Pharmacy Groups Say Draft Medicaid FULs Could Lead To Rx Access Issues
GAO And Legislators Pushing HHS For Stronger 340B Oversight
Average Manufacturer Prices For Medicaid Drugs Are Publicly Available For First Time
Bipartisan Bill Expanding 340B Discounts To Inpatient Drugs Introduced In House
Medicaid Average Manufacturer Price Reg Is Written, Now Pending HHS And OMB Review

Topics

Advertisement
UsernamePublicRestriction

Register

PS054104

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel